Phibro Animal Health (PAHC) Updates FY19 Earnings Guidance

Share on StockTwits

Phibro Animal Health (NASDAQ:PAHC) updated its FY19 earnings guidance on Tuesday. The company provided earnings per share guidance of $1.68-1.72 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.75. Phibro Animal Health also updated its FY 2019 guidance to $1.68-1.72 EPS.

A number of equities analysts recently weighed in on the stock. BidaskClub raised shares of Phibro Animal Health from a hold rating to a buy rating in a research report on Wednesday, August 8th. Morgan Stanley increased their price objective on shares of Phibro Animal Health from $36.00 to $46.00 and gave the stock an underweight rating in a research report on Wednesday, August 29th. Finally, Zacks Investment Research cut shares of Phibro Animal Health from a hold rating to a sell rating in a research report on Wednesday, August 29th. Three research analysts have rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the stock. The company currently has a consensus rating of Hold and an average target price of $43.20.

NASDAQ:PAHC opened at $42.18 on Wednesday. The company has a debt-to-equity ratio of 1.62, a current ratio of 2.90 and a quick ratio of 1.66. The company has a market cap of $1.71 billion, a P/E ratio of 24.24, a P/E/G ratio of 3.55 and a beta of 0.82. Phibro Animal Health has a fifty-two week low of $32.05 and a fifty-two week high of $54.62.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings data on Tuesday, November 6th. The company reported $0.39 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.41 by ($0.02). The company had revenue of $200.20 million for the quarter, compared to analysts’ expectations of $203.99 million. Phibro Animal Health had a return on equity of 39.81% and a net margin of 7.90%. The business’s revenue for the quarter was up 3.5% on a year-over-year basis. During the same period in the previous year, the business posted $0.38 EPS. As a group, equities analysts forecast that Phibro Animal Health will post 1.75 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 19th. Investors of record on Wednesday, November 28th will be given a dividend of $0.12 per share. The ex-dividend date of this dividend is Tuesday, November 27th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.14%. This is a boost from Phibro Animal Health’s previous quarterly dividend of $0.10. Phibro Animal Health’s dividend payout ratio (DPR) is presently 22.99%.

In other Phibro Animal Health news, insider Jack Bendheim sold 30,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 15th. The shares were sold at an average price of $49.75, for a total value of $1,492,500.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, VP Daniel M. Bendheim sold 2,500 shares of the firm’s stock in a transaction that occurred on Wednesday, September 12th. The shares were sold at an average price of $44.30, for a total transaction of $110,750.00. Following the completion of the transaction, the vice president now directly owns 2,500 shares of the company’s stock, valued at approximately $110,750. The disclosure for this sale can be found here. Insiders have sold a total of 143,020 shares of company stock valued at $6,967,571 in the last ninety days. 50.29% of the stock is currently owned by corporate insiders.

TRADEMARK VIOLATION WARNING: “Phibro Animal Health (PAHC) Updates FY19 Earnings Guidance” was reported by Week Herald and is the sole property of of Week Herald. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The legal version of this article can be read at

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

See Also: Price to Earnings Ratio (PE) Basics

Earnings History and Estimates for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with's FREE daily email newsletter.

Leave a Reply